White Paper
Fill-Finish Biologics
![Fill-Finish Biologics](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_product_file/publications/pharmaceutical-science/biopharma-reporter.com/resources/fill-finish-packaging/fill-finish-biologics/15417508-1-eng-GB/Fill-Finish-Biologics.jpg)
The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for biologics is projected to increase to $537 billion, while the blockbuster Keytruda could be the top-selling drug with almost $25 billion in sales.